Personal information

HCV, Hepatitis C, Design, Synthesis, Molecular Docking, Quinolone, Phthalamide
Iran

Activities

Employment (1)

Shahid Kazemi Pharmacy: Tehran, Tehran, IR

Doctor of Pharmacy
Employment
Source: Self-asserted source
Mohammad Mahboubi-Rabbani

Education and qualifications (1)

Shahid Beheshti University of Medical Sciences School of Pharmacy: Tehran, Tehran, IR

2006-01 to 2019-10 | PharmD, PhD (Medicinal Chemistry)
Education
Source: Self-asserted source
Mohammad Mahboubi-Rabbani

Works (13)

A critical review on sodium benzoate from health effects to analytical methods

Results in Chemistry
2024-10 | Journal article | Conceptualization
Part of ISSN: 2211-7156
Contributors: Leila Hejazi; Mohammad Mahboubi-Rabbani; Vahideh Mahdavi; Mehrdad Alemi; elham khanniri; Maryam Bayanati; Mohammad Mahboubi-Rabbani
Source: Self-asserted source
Mohammad Mahboubi-Rabbani

Design, Synthesis, molecular dynamic analysis, and In-Vivo anti-diabetic evaluation of novel hydrazine carboximidamide derivatives

Results in Chemistry
2024-10 | Journal article
Part of ISSN: 2211-7156
Contributors: Hannane Fathi; Nima Naderi; Seyedali Hashemi; Yasaman Pourbaba; Amir Garmabdari; Elham Rezaee; Mohammad Mahboubi-Rabbani; Sayyed Abbas Tabatabai
Source: Self-asserted source
Mohammad Mahboubi-Rabbani

Selective COX-2 inhibitors as anticancer agents: a patent review (2018-2023)

Expert Opinion on Therapeutic Patents
2024-09 | Journal article
Part of ISSN: 1354-3776
Part of ISSN: 1744-7674
Contributors: Mohammad Mahboubi-Rabbani; Amir Hossein Abdolghaffari; Mahsa Ghesmati; Ali Amini; Afshin Zarghi
Source: Self-asserted source
Mohammad Mahboubi-Rabbani

Design, Synthesis, and In‐Vitro Evaluation of Novel Butanoic Acid Derivatives as Potential Soluble Epoxide Hydrolase Inhibitors

ChemistrySelect
2024-02-26 | Journal article
Part of ISSN: 2365-6549
Part of ISSN: 2365-6549
Contributors: Saeedeh Saeedi; Mohammad Mahboubi‐Rabbani; Elham Rezaee; Sayyed Abbas Tabatabai
Source: Self-asserted source
Mohammad Mahboubi-Rabbani

Novel Benzo[4,5]imidazo[1,2-a]pyrimidine derivatives as selective Cyclooxygenase-2 Inhibitors: Design, synthesis, docking studies, and biological evaluation

Medicinal Chemistry Research
2023-03 | Journal article
Part of ISSN: 1054-2523
Part of ISSN: 1554-8120
Contributors: Maryam Bayanati; Mona Khoramjouy; Mehrdad Faizi; Mahsa Azami Movahed; Mohammad Mahboubi-Rabbani; Afshin Zarghi
Source: Self-asserted source
Mohammad Mahboubi-Rabbani

A Concise and Efficient CuI-catalyzed Synthesis of Diimino Dihydroquinazoline Derivatives from Isocyanides and Guanidines Derivatives Through Intramolecular C-H Activation

Letters in Organic Chemistry
2022-01 | Journal article
Contributors: Manijeh Nematpour; Hossein Fasihi Dastjerdi; Mohammad Mahboubi-Rabbani
Source: check_circle
Crossref

Copper-Catalyzed Ultrasonic-Promoted Coupling of Acetylene Analogs, Dialkyl azo dicarboxylate, and Benzazoles to Assemble Tricyclic Fused- Ring [1,2,3]triazolo[3,4-b][1,3]benzazole Analogs

Letters in Organic Chemistry
2022-01 | Journal article
Contributors: Manijeh Nematpour; Nafiseh Karimi; Mohammad Mahboubi-Rabbani
Source: check_circle
Crossref

Dual Human Carbonic Anhydrase/Cyclooxygenase-2 Inhibitors: A Promising Approach for Cancer Treatment

Anti-Cancer Agents in Medicinal Chemistry
2021-11 | Journal article
Contributors: Mohammad Mahboubi-Rabbani; Afshin Zarghi
Source: check_circle
Crossref

Copper-Catalyzed Intramolecular N-Arylation of Dihalobenzene and Amine-Trichloroacetonitrile Adduct under Ultrasound-Irradiation

ChemistrySelect
2019 | Journal article
EID:

2-s2.0-85073220418

Contributors: Nematpour, M.; Fasihi Dastjerdi, H.; Mahboubi Rabbani, S.M.I.; Tabatabai, S.A.
Source: Self-asserted source
Mohammad Mahboubi-Rabbani via Scopus - Elsevier

Copper-Catalyzed N-Arylation of Polysubstituted Pyridines Synthesized by the Novel Reaction of N-Sulfonyl Ketenimine and Malononitrile-Trichloroacetonitrile Adduct

Journal of Heterocyclic Chemistry
2019 | Journal article
EID:

2-s2.0-85070746099

Contributors: Nematpour, M.; Fasihi Dastjerdi, H.; Mahboubi Rabbani, S.M.I.; Tabatabai, S.A.
Source: Self-asserted source
Mohammad Mahboubi-Rabbani via Scopus - Elsevier

Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018)

Expert Opinion on Therapeutic Patents
2019 | Journal article
EID:

2-s2.0-85066933288

Contributors: Mahboubi Rabbani, S.M.I.; Zarghi, A.
Source: Self-asserted source
Mohammad Mahboubi-Rabbani via Scopus - Elsevier

Lipoxygenase inhibitors as cancer chemopreventives: discovery, recent developments, and future perspectives

Current Medicinal Chemistry
2019-12-10 | Journal article
Part of ISSN: 0929-8673
Source: Self-asserted source
Mohammad Mahboubi-Rabbani
grade
Preferred source (of 2)‎

Design, Synthesis, Molecular Modeling Studies and Biological Evaluation of Arylidene 6--( 4 oxo 1,4 dihydroquinoline 3 carbohydrazide Derivatives as Novel Anti HCV Agents

Iranian Journal of Pharmaceutical Research
2019-10-09 | Journal article
Source: Self-asserted source
Mohammad Mahboubi-Rabbani

Peer review (4 reviews for 3 publications/grants)

Review activity for Bioorganic chemistry. (1)
Review activity for Brain, behavior, and immunity. (1)
Review activity for Journal of the Iranian Chemical Society. (2)